JD Health InternationalJDHIF 90 PE Ratio (TTM) is 24.68 as of Jun. 29, 2026, which is 35% below its 10-year median of 38.24. GuruFocus rates JDHIF with a GF Score™ of 90/100 and a GF Value™ of $10.42. The stock has 1 warning sign investors should review. Among 430 Healthcare Providers & Services companies, JD Health International ranks better than 57.67% on this metric.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-06-29), JD Health International's share price is
$5.85.
JD Health International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.24. Therefore, JD Health International's PE Ratio (TTM) for today is 24.68.
Good Sign:
JD Health International Inc stock PE Ratio (=17.23) is close to 5-year low of 17.23.
The historical rank and industry rank for JD Health International's PE Ratio (TTM) or its related term are showing as below:
JDHIF'
s PE Ratio (TTM) Range Over the Past 10 Years
Min: 17.23 Med: 38.24 Max: 523.88
Current: 17.32
During the past 9 years, the highest PE Ratio (TTM) of JD Health International was 523.88. The lowest was 17.23. And the median was 38.24.
JDHIF's PE Ratio (TTM) is ranked better than 57.67% of 430
companies
in the Healthcare Providers & Services industry
Industry Median: 21.585
vs JDHIF: 17.32
During the past 9 years, JD Health International's highest 3-Year average EPS without NRI Growth Rate was 128.10% per year. The lowest was 128.10% per year. And the median was 128.10% per year.
JD Health International (OTCPK:JDHIF) PE Ratio (TTM) Explanation
The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.
If a company loses money, the PE Ratio (TTM) becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.
Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .
PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).
JD Health International PE Ratio (TTM) Related Terms
JD Health International PE Ratio (TTM) Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JD Health International PE Ratio (TTM) Competitor Comparison
For the Pharmaceutical Retailers subindustry, JD Health International's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JD Health International PE Ratio (TTM) vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, JD Health International's PE Ratio (TTM) distribution charts can be found below:
* The bar in red indicates where JD Health International's PE Ratio (TTM) falls into.
JD Health International PE Ratio (TTM) Calculation
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.
JD Health International's Share Price of today is $5.85.
For company reported semi-annually, JD Health International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.24.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
JD Health International (JDHIF) has a PE Ratio (TTM) of 24.68 as of Jun. 29, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on JD Health International and its competitors. This is 35% below median its historical median of 38.24. Over the past decade, JD Health International's PE Ratio (TTM) has ranged from 17.23 to 523.88. According to the industry distribution chart, JD Health International ranks #182 out of 430 companies in the Healthcare Providers & Services industry, placing it in the top 42.3%.
Is JD Health International's PE Ratio (TTM) too high?
JD Health International's current PE Ratio (TTM) of 24.68 is 35% below median its 10-year median of 38.24. Over the past 10 years, this metric has ranged from a low of 17.23 to a high of 523.88. The Healthcare Providers & Services industry median PE Ratio (TTM) is 21.59. JD Health International's value of 24.68 is 14.3% above this industry median. Based on the distribution chart, JD Health International ranks #182 out of 430 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, JD Health International has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does JD Health International's PE Ratio (TTM) compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, JD Health International ranks #182 out of 430 companies for PE Ratio (TTM). This puts JD Health International in the upper half of its industry. The industry median PE Ratio (TTM) is 21.59. JD Health International's value of 24.68 is 14.3% above this benchmark. Historically, JD Health International's own PE Ratio (TTM) has ranged from 17.23 to 523.88 over the past decade. While the company's 10-year median is 38.24 vs. the industry median of 21.59, JD Health International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Healthcare Providers & Services company?
The median PE Ratio (TTM) among Healthcare Providers & Services companies is 21.59, based on 430 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JD Health International's current PE Ratio (TTM) of 24.68 is 14.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on JD Health International and its competitors. For the Healthcare Providers & Services industry, the median PE Ratio (TTM) is 21.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JD Health International's current PE Ratio (TTM) is 24.68, which is 35% below median its own 10-year median of 38.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JD Health International stock overvalued right now?
JD Health International (JDHIF) has a current PE Ratio (TTM) of 24.68. The stock's GF Value™ is $10.42, compared to a current price of $5.85 — trading 43.9% below its estimated fair value. The current PE Ratio (TTM) is 24.68, which is 35% below median its 10-year median of 38.24 and 14.3% above the Healthcare Providers & Services industry median of 21.59. JD Health International's overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For JD Health International (JDHIF), the current PE Ratio (TTM) is 24.68 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JD Health International (JDHIF) Overvalued in 2026?
Based on GuruFocus' analysis, JD Health International stock appears to be undervalued.
The current stock price of $5.85 is trading 43.9% below its estimated GF Value™ of $10.42.
Key valuation signals for JDHIF:
PE Ratio (TTM): 24.68 (35% below median its 10-year median of 38.24)
GF Value™: $10.42 vs. price of $5.85 (43.9% below fair value)
Industry Position: 14.3% above the Healthcare Providers & Services median (#182 of 430)
No single metric tells the full story. See the JDHIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health and Meituan for its e-commerce business. As of Dec. 31, 2024, the platform has over 200 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
90GF Score
Get the complete analysis for JDHIF
PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JDHIF has been successfully added to your 
